HUP0004428A3 - A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine - Google Patents

A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine

Info

Publication number
HUP0004428A3
HUP0004428A3 HU0004428A HUP0004428A HUP0004428A3 HU P0004428 A3 HUP0004428 A3 HU P0004428A3 HU 0004428 A HU0004428 A HU 0004428A HU P0004428 A HUP0004428 A HU P0004428A HU P0004428 A3 HUP0004428 A3 HU P0004428A3
Authority
HU
Hungary
Prior art keywords
propoxyphenoxy
isopropyl
amine
ethyl
methyl
Prior art date
Application number
HU0004428A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0004428A2 publication Critical patent/HUP0004428A2/hu
Publication of HUP0004428A3 publication Critical patent/HUP0004428A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0004428A 1997-12-22 1998-12-15 A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine HUP0004428A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704835A SE9704835D0 (sv) 1997-12-22 1997-12-22 New compound
PCT/SE1998/002316 WO1999032431A1 (en) 1997-12-22 1998-12-15 A NOVEL PHOSPHATE SALT OF ISOPROPYL-METHYL-[2-(3-n-PROPOXYPHENOXY)ETHYL]AMINE

Publications (2)

Publication Number Publication Date
HUP0004428A2 HUP0004428A2 (hu) 2002-03-28
HUP0004428A3 true HUP0004428A3 (en) 2002-04-29

Family

ID=20409538

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004428A HUP0004428A3 (en) 1997-12-22 1998-12-15 A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine

Country Status (22)

Country Link
US (1) US6235792B1 (hu)
EP (1) EP1047663A1 (hu)
JP (1) JP2001526254A (hu)
KR (1) KR20010033407A (hu)
CN (1) CN1280559A (hu)
AR (1) AR017199A1 (hu)
AU (1) AU1989299A (hu)
BR (1) BR9814381A (hu)
CA (1) CA2314989A1 (hu)
EE (1) EE200000384A (hu)
HU (1) HUP0004428A3 (hu)
ID (1) ID26940A (hu)
IL (1) IL136829A0 (hu)
IS (1) IS5544A (hu)
NO (1) NO20003216D0 (hu)
PL (1) PL341525A1 (hu)
SE (1) SE9704835D0 (hu)
SK (1) SK8062000A3 (hu)
TR (1) TR200002012T2 (hu)
TW (1) TW455590B (hu)
WO (1) WO1999032431A1 (hu)
ZA (1) ZA9811237B (hu)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
AR004691A1 (es) 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
NO20003216L (no) 2000-06-21
CA2314989A1 (en) 1999-07-01
WO1999032431A1 (en) 1999-07-01
HUP0004428A2 (hu) 2002-03-28
EP1047663A1 (en) 2000-11-02
SE9704835D0 (sv) 1997-12-22
IS5544A (is) 2000-06-21
ZA9811237B (en) 1999-07-19
KR20010033407A (ko) 2001-04-25
NO20003216D0 (no) 2000-06-21
TW455590B (en) 2001-09-21
JP2001526254A (ja) 2001-12-18
CN1280559A (zh) 2001-01-17
BR9814381A (pt) 2000-10-10
PL341525A1 (en) 2001-04-23
EE200000384A (et) 2001-12-17
SK8062000A3 (en) 2001-02-12
AR017199A1 (es) 2001-08-22
TR200002012T2 (tr) 2000-10-23
IL136829A0 (en) 2001-06-14
US6235792B1 (en) 2001-05-22
AU1989299A (en) 1999-07-12
ID26940A (id) 2001-02-22

Similar Documents

Publication Publication Date Title
EP1039890A4 (en) METFORMIN SALTS AND METHOD
PL337505A1 (en) 4"-substituted derivatives of 9-deoxo-9a-aza-9a-homoerythromycin a
PL339898A1 (en) Singular aligning of a mould
AP9801266A0 (en) Tartrate salt of a substituted dipeptide
IL124993A0 (en) Apo b-secretion/mtp inhibitor hydrochloride salt
EG23836A (en) A novel salt
HUP0004358A2 (en) Method of preparing a dairy spread
PL330798A1 (en) Crystalline form of a pharmaceutic agent
IL131660A0 (en) Process for preparation of pesticidal intermediates
HK1028619A1 (en) Process for the preparation of a polyamide-polyurethane micro-blend
HK1025575A1 (en) A new salt
ZA986320B (en) A method for the preparation of tertiary amines a compound useful therefor and alpha-2-receptor active tetrahyd-roisoquinoline derivatives
EP1003502A4 (en) ENANTIOMERS OF 4- (CYANOIMINO) - (1,2,2-TRIMETHYLPROPYL) AMINO] METHYL] AMINO] BENZONITRIL
PL345542A1 (en) Novel salts of n-tert-butylhydroxylamine
HUP0004428A3 (en) A novel phosphate salt of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine
AU135656S (en) A set of measuring cups
IL136825A0 (en) Process for the preparation of isopropyl-methyl-[2-(3-n-propoxyphenoxy)ethyl]amine
GB2354467B (en) Method of providing a structural member
GB9618371D0 (en) Novel use of a known compound
IL122009A0 (en) Salt of a bisphosphonic acid derivative
GB2343686B (en) A set of parts
IL133491A0 (en) Preparation of a recording carrier
HUP0001457A3 (en) Novel therapeutic application of a thienycyclohexylamine derivative
LT97197A (en) A intermin mark of a number of a vevicle
ZA9811474B (en) Novel amines of pharmaceutical agents